International consensus diagnostic criteria for neuromyelitis optica spectrum disorders
Citation Manager Formats
Make Comment
See Comments

Abstract
Neuromyelitis optica (NMO) is an inflammatory CNS syndrome distinct from multiple sclerosis (MS) that is associated with serum aquaporin-4 immunoglobulin G antibodies (AQP4-IgG). Prior NMO diagnostic criteria required optic nerve and spinal cord involvement but more restricted or more extensive CNS involvement may occur. The International Panel for NMO Diagnosis (IPND) was convened to develop revised diagnostic criteria using systematic literature reviews and electronic surveys to facilitate consensus. The new nomenclature defines the unifying term NMO spectrum disorders (NMOSD), which is stratified further by serologic testing (NMOSD with or without AQP4-IgG). The core clinical characteristics required for patients with NMOSD with AQP4-IgG include clinical syndromes or MRI findings related to optic nerve, spinal cord, area postrema, other brainstem, diencephalic, or cerebral presentations. More stringent clinical criteria, with additional neuroimaging findings, are required for diagnosis of NMOSD without AQP4-IgG or when serologic testing is unavailable. The IPND also proposed validation strategies and achieved consensus on pediatric NMOSD diagnosis and the concepts of monophasic NMOSD and opticospinal MS.
GLOSSARY
- ADEM=
- acute disseminated encephalomyelitis;
- AQP4=
- aquaporin-4;
- IgG=
- immunoglobulin G;
- IPND=
- International Panel for NMO Diagnosis;
- LETM=
- longitudinally extensive transverse myelitis lesions;
- MOG=
- myelin oligodendrocyte glycoprotein;
- MS=
- multiple sclerosis;
- NMO=
- neuromyelitis optica;
- NMOSD=
- neuromyelitis optica spectrum disorders;
- SLE=
- systemic lupus erythematosus;
- SS=
- Sjögren syndrome
Footnotes
Go to Neurology.org for full disclosures. Funding information and disclosures deemed relevant by the authors, if any, are provided at the end of the article. The Article Processing Charge was paid by the Guthy-Jackson Charitable Foundation.
Editorial, page 118
Supplemental data at Neurology.org
- Received September 30, 2014.
- Accepted in final form January 28, 2015.
- © 2015 American Academy of Neurology
This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License 4.0 (CC BY-NC-ND), which permits downloading and sharing the work provided it is properly cited. The work cannot be changed in any way or used commercially.
Letters: Rapid online correspondence
- Age and NMOSD Diagnosis
- Dean M. Wingerchuk, Mayo Clinic, Scottsdale, AZwingerchuk.dean@mayo.edu
- Brian G. Weinshenker, Rochester, MN
Submitted August 28, 2015 - Late-onset NMOSD: another diagnostic challenge
- Zhifeng Mao, Physician, Multiple Sclerosis Center, Dept. of Neurology, Third Affiliated Hospital of Sun Yat-Sen Universitymaozfx@qq.com
- Wei Qiu, Guangzhou, China; Xueqiang Hu, Guangzhou, China
Submitted August 26, 2015 - Definitive diagnosis of NMOSD without AQP4-IgG is preferable to a "probable" category
- Dean M. Wingerchuk, Mayo Clinic, Scottsdale, AZwingerchuk.dean@mayo.edu
- Brian G. Weinshenker, Rochester, MN
Submitted July 28, 2015 - Patients with AQP4-IgG negative or unknown should be classified as "probable NMO"
- Chong Tin Tan, Professor, Division of Neurology, University of Malayachongtin.tan@gmail.com
Submitted July 24, 2015
REQUIREMENTS
If you are uploading a letter concerning an article:
You must have updated your disclosures within six months: http://submit.neurology.org
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
More Online
Hemiplegic Migraine Associated With PRRT2 Variations A Clinical and Genetic Study
Dr. Robert Shapiro and Dr. Amynah Pradhan